Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01163578 · ClinicalTrials.gov registry record

Biomarkers in Transplant Recipients to Improve Outcomes

A clinical trial of Bone Marrow Transplantation and Solid Organ Transplantation, sponsored by University of Pittsburgh.

Recruiting
Registry status
1,200
Enrollment target
1
Study location

NCT01163578 is a study of Bone Marrow Transplantation and Solid Organ Transplantation that is actively recruiting participants, run by University of Pittsburgh. The registered enrollment target is 1,200 participants, above the 113-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (962% higher). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01163578, a study of Bone Marrow Transplantation and Solid Organ Transplantation, is actively recruiting participants, sponsored by University of Pittsburgh.

RECRUITING
Registry status
1,200 participants
Enrollment target
1
Study location

Study Summary

The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

Study Locations (1)

Pennsylvania

  • Children's Hospital of Pittsburgh of UPMC - Pittsburgh

Trial Details

FieldValue
Enrollment Target 1,200 participants
Start Date 2005-03
Est. Completion 2030-03

Sponsor

University of Pittsburgh

1,238 total trials

What the Registry Record Tells You About NCT01163578

The ClinicalTrials.gov registry entry for NCT01163578 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,200 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 113-participant average among 5 other Bone Marrow Transplantation trials with a reported enrollment target (962% higher). The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Bone Marrow Transplantation appearing as the primary indexed condition, and to 0 interventions.

NCT01163578 reports 1 study location spanning 1 distinct geographic area - top geographies include Pennsylvania.

Frequently Asked Questions

What is clinical trial NCT01163578 about?

NCT01163578 is a clinical study titled "Biomarkers in Transplant Recipients to Improve Outcomes". The objective of this study is to evaluate whether certain proteins, expressed in biological tissues can indict a better understanding of the effect of drugs that are used to treat rejection, and of processes leading to rejection and rejection-free outcomes.

What is the current status of trial NCT01163578?

This trial is currently recruiting. The enrollment target is 1,200 participants. The study started on 2005-03. Estimated completion is 2030-03.

What conditions does trial NCT01163578 study?

This clinical trial studies the following conditions: Bone Marrow Transplantation, Solid Organ Transplantation.

Who is sponsoring clinical trial NCT01163578?

This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01163578 being conducted?

This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Bone Marrow Transplantation

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.